Recurrent Massive Hydrothorax in a Patient with Decompensated Liver Cirrhosis

   Aim: to demonstrate the need for a detailed differential diagnosis and selection of therapy in a patient with decompensated liver cirrhosis of combined etiology (HCV infection and primary sclerosing cholangitis).

   Key points. The patient came to the clinic with complaints of shortness of breath with minimal physical activity, abdominal enlargement, swelling of the legs, yellowness of the skin, and severe weakness. The complaints arose two months after suffering from left-sided focal pneumonia. Laboratory tests revealed signs of systemic inflammation, liver failure, and acute kidney injury. According to the results of instrumental studies, massive hydrothorax was noted in the right pleural cavity. The patient underwent a series of thoracentesis, and a total of about four liters of non-inflammatory pleural fluid was evacuated. Differential diagnosis was based on the presence of dyspnea and respiratory failure. The patient received effective antiviral therapy with drugs using an interferon-free regimen. Subsequently, conservative therapy was carried out, against the background of which the symptoms regressed and the patient’s condition improved.

   Conclusions. Hepatopleural syndrome is a serious complication in patients with decompensated liver cirrhosis, although it does not always appear secondary to massive ascites. To resolve hepatic hydrothorax, it is necessary to carry out diuretic therapy, replacement transfusion therapy with albumin preparations, and if there is a large amount of fluid in the pleural cavities, therapeutic and diagnostic thoracentesis is recommended.

1. Ivashkin V.T., Maevskaya M.V., Zharkova M.S., Zhigalova S.B., Kitsenko E.A., Manukyan G.V., et al. Clinical recommendations of the Russian Scientific Liver Society and Russian Gastroenterological Association on diagnosis and treatment of liver fibrosis, cirrhosis and their complications. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2021;31(6):56–102. (In Russ.)

2. Alhmada Y., Selimovic D., Murad F., Hassan S.L., Haikel Y., Megahed M., et al. Hepatitis C virus-associated pruritus: Etiopathogenesis and therapeutic strategies. World J Gastroenterol. 2017;23(5):743–50. DOI: 10.3748/wjg.v23.i5.743

3. Volgina G.V., Kozlovskaya N.L., Shchekochikhin D.Yu. Clinical guidelines for the prevention, diagnosis and treatment of contrast-induced nephropathy. Scientific Society of Nephrologists of Russia. 2013. (In Russ.) URL: http://endovascular-society.ru/download/guidelines_2/CIN_rus.pdf

4. Smirnov A.V., Dobronravov V.A., Rumyantsev A.S., Shilov E.M., Vatazin A.V., Kayukov I.G., et al. National guidelines. Acute kidney injury: Basic principles of diagnosis, prevention and therapy. Part I. Nephrology (Saint-Petersburg). 2016;20(1):79–104. (In Russ.) DOI: 10.24884/1561-6274-2016-20-1-8-15

5. Demirtas C.O., Brunetto M.R. Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it? World J Gastroenterol. 2021;27(33): 5536–54. DOI: 10.3748/wjg.v27.i33.5536

6. Craciun R., Mocan T., Procopet B., Nemes A., Tefas C., Sparchez M., et al. Pulmonary complications of portal hypertension: The overlooked decompensation. World J Clin Cases. 2022;10(17):5531–40. DOI: 10.12998/wjcc.v10.i17.5531

7. Shtonda M.V., Silivontchik N.N., Bankova A.M., Petrov S.A., Semenenkova A.N., Sukhikh Z.L. Pulmonary diseases and syndromes in patients with decompensated cirrhosis of the liver. Lechebnoe delo. 2023;3(86): 46–50. (In Russ.)

8. Ivashkin V.T. Complications of portal hypertension in liver cirrhosis. Russian Journal of Physiology. 2009;95(10):1074–92. (In Russ.)

9. Strauss R.M., Boyer T.D. Hepatic hydrothorax. Semin Liver Dis. 1997;17(3):227–32. DOI: 10.1055/s-2007-1007200

10. Garcia N. Jr, Mihas A.A. Hepatic hydrothorax: pathophysiology, diagnosis, and management. J Clin Gastroenterol. 2004;38(1):52–8. DOI: 10.1097/00004836-200401000-00012

11. Roussos A., Philippou N., Mantzaris G.J., Gourgouliannis K.I. Hepatic hydrothorax: Pathophysiology diagnosis and management. J Gastroenterol Hepatol. 2007;22(9):1388–93. DOI: 10.1111/j.1440-1746.2007.05069.x

12. Rozina T.P., Esmembetov K., Abdurakhmanov D.T., Sorokin Yu.D., Osipenko V.I., Sapozhnikov D.V. Recurrent hepatic hydrothorax in a patient with liver cirrhosis. Clinical Hepatology. 2009;4:30. (In Russ.)

13. European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, & European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406–60. DOI: 10.1016/j.jhep.2018.03.024

14. Benz F., Mohr R., Tacke F., Roderburg C. Pulmonary complications in patients with liver cirrhosis. J Transl Int Med. 2020;8(3):150–8. DOI: 10.2478/jtim-2020-0024

15. Sussman N.L. Pulmonary complications of cirrhosis. Gastroenterol Hepatol (N Y). 2015;11(2):126–8.

16. Than N.N. Pulmonary complications of liver cirrhosis : A concise review. InTech; 2017. doi: 10.5772/intechopen.68620

17. Soulaidopoulos S., Goulis I., Cholongitas E. Pulmonary manifestations of chronic liver disease : A comprehensive review. Ann Gastroenterol. 2020;33(3):237–49. DOI: 10.20524/aog.2020.0474

18. Garbuzenko D.V., Arefyev N.O. Hepatic hydrothorax : An update and review of the literature. World J Hepatol. 2017;9(31):1197–204. doi: 10.4254/wjh.v9.i31.1197

19. Pippard B., Bhatnagar M., McNeill L., Donnelly M., Frew K., Aujayeb A. Hepatic hydrothorax : A narrative review. Pulm Ther. 2022;8(3):241–54. DOI: 10.1007/s41030-022-00195-8